Noncontraceptive health benefits of combined oral contraception
review
OA: closed
CC0
⤵ 19 in-corpus citations
Abstract
Contraception is one of the keystones of reproductive health. The availability of effective contraception has helped to change dramatically the structure of the world's population during the last 50 years, through a demographic transition involving lower fertility rates and longer survival. As the transition evolves more slowly in developing countries, different effects on population structures contribute to civil strains. Oral contraception (OC) is an extremely effective method of contraception that also confers health benefits beyond pregnancy prevention. Notable effects on the reproductive system include relief from troublesome symptoms associated with menstruation such as heavy periods, painful periods and irregular bleeding. Many women also have improvement in acne and hirsutism. Moreover, OCs may be used to treat menorrhagia or symptomatic endometriosis. Use of OCs is associated with a long lasting reduction in the risk of developing cancer of the ovary and the endometrium. The effects on benign breast disease (BBD), bone health and colon cancer are less clear and merit further investigation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex
- A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Endometriosis via openalex
- Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial via openalex
- Lasting response to ovariectomy in severe intractable premenstrual syndrome via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W1967189655 via openalex
- W1970301569 via openalex
- W1970410490 via openalex
- W1972763356 via openalex
- W1973795818 via openalex
- W1974936404 via openalex
- W1976166811 via openalex
- W1976923360 via openalex
- W1977489294 via openalex
- W1979931849 via openalex
- W1980987125 via openalex
- W1981612254 via openalex
- W1984740500 via openalex
- W1986175627 via openalex
- W1988353419 via openalex
- W1989125153 via openalex
- W1989733741 via openalex
- W1989775353 via openalex
- W1992385877 via openalex
- W1995437690 via openalex
- W1996275849 via openalex
- W1996791199 via openalex
- W1998293271 via openalex
- W2000796684 via openalex
- W2002092283 via openalex
- W2005153538 via openalex
- W2007914086 via openalex
- W2009640550 via openalex
- W2009711336 via openalex
- W2010417484 via openalex
- W2012165536 via openalex
- W2014017175 via openalex
- W2017908140 via openalex
- W2022753015 via openalex
- W2022871441 via openalex
- W2024889666 via openalex
- W2031423046 via openalex
- W2033358136 via openalex
- W2042925173 via openalex
- W2046872387 via openalex
- W2047582202 via openalex
- W2055832348 via openalex
- W2059442967 via openalex
- W2059559261 via openalex
- W2065227580 via openalex
- W2065513086 via openalex
- W2065614931 via openalex
- W2068331006 via openalex
- W2069392551 via openalex
- W2070353726 via openalex
- W2070796663 via openalex
- W2071361972 via openalex
- W2071832698 via openalex
- W2072849805 via openalex
- W2073447813 via openalex
- W2073740640 via openalex
- W2073999645 via openalex
- W2074953761 via openalex
- W2075712741 via openalex
- W2079008410 via openalex
- W2080156869 via openalex
- W2080162691 via openalex
- W2085146583 via openalex
- W2088158971 via openalex
- W2092383296 via openalex
- W2093065112 via openalex
- W2094252128 via openalex
- W2105045370 via openalex
- W2106377908 via openalex
- W2112510101 via openalex
- W2114800362 via openalex
- W2116013437 via openalex
- W2116297033 via openalex
- W2119529166 via openalex
- W2122654402 via openalex
- W2123898987 via openalex
- W2126560499 via openalex
- W2128914859 via openalex
- W2131136151 via openalex
- W2135479733 via openalex
- W2138117830 via openalex
- W2150038365 via openalex
- W2153093812 via openalex
- W2154988334 via openalex
- W2157787515 via openalex
Cited by (19)
- Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue 2021
- Non-contraceptive Benefits of Hormonal Methods 2021
- Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under 2020
- Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review. 2019
- A high resolution LC–MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids 2019
- Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review 2019
- Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (<i>PTGS2</i>) Expression in Endometriotic Tissues 2013
- Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: An observational, preliminary study 2013
- Elevated immunoreactivity of RANTES and CCR1 correlate with the severity of stages and dysmenorrhea in women with deep infiltrating endometriosis 2012
- Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems 2012
- Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis 2011
- Management of Menorrhagia Associated with Chemotherapy‐Induced Thrombocytopenia in Women with Hematologic Malignancy 2011
- Semi-invasive Diagnosis of Endometriosis Doctoral Thesis 2010
- A New Estradiol-Dienogest Oral Contraceptive Marks “The Pill's” 50th Anniversary 2010
- La contraccezione ormonale oggi 2009
- The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas 2009
- Oral contraceptives prevent the development of endometriosis in the chicken chorioallantoic membrane model 2008
- Non-contraceptive benefits of oral contraceptives 2008
- Emerging drugs in endometriosis 2006
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0
· commercial use OK